Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group (Q45230542)
Jump to navigation
Jump to search
scientific article published in January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group |
scientific article published in January 2005 |
Statements
1 reference
Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group (English)
1 reference
C M Canil
1 reference
M J Moore
1 reference
E Winquist
1 reference
T Baetz
1 reference
M Pollak
1 reference
K N Chi
1 reference
S Berry
1 reference
D S Ernst
1 reference
L Douglas
1 reference
M Brundage
1 reference
B Fisher
1 reference
A McKenna
1 reference
L Seymour
1 reference
1 January 2005
1 reference
1 reference
23
1 reference
3
1 reference
455-460
1 reference
Identifiers
1 reference
1 reference